Lee Lueder

Analyst Lee Lueder, carries an average stock price target met ratio of 90.83% that have a potential upside of 18.05% achieved within 103 days. Previously, Lee Lueder worked at DEUTSCHE BANK.

Lee Lueder’s has documented 32 price targets and ratings displayed on 4 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on CRL, Charles River Laboratories at 18-Dec-2023.

Wall Street Analyst Lee Lueder

Analyst best performing recommendations are on IQV (IQVIA HOLDINGS).
The best stock recommendation documented was for CRL (CHARLES RIVER LABORATORIES) at 11/9/2023. The price target of $215 was fulfilled within 34 days with a profit of $45.53 (26.87%) receiving and performance score of 7.9.

Average potential price target upside

• of $40.75 (31.23%) on IQV (IQVIA HOLDINGS).
• of $28.24 (13.73%) on CRL (CHARLES RIVER LABORATORIES).
• of $10.03 (12.12%) on CTLT (CATALENT).